Yumble 1450 Broadway, 40th FloorNew York, NY 10018http://www.yumblekids.com/ Key contact Name Title David Parker CEO & Co-Founder NEW YORK, NY, Yumble, a healthy kids' meal brand, has raised $7 million in Series A funding, bringing its total funding tally to $8.5 million. Yumble announced it has closed Series A funding led by Sonoma Brands, along […]
Archivio Categoria: series A
19
Set
Set
Silverback Therapeutics 500 Fairview Ave. N #600Seattle, WA 98109206-456-2900https://silverbacktx.com/ Key contact Name Title Peter Thompson CEO SEATTLE, WA, Biotechnology company developing a pipeline of systemically delivered has closed an extension of its Series A financing. Silverback Therapeutics, Inc., a biotechnology company developing a pipeline of systemically delivered, locally active therapies, has closed an extension of […]
OODA Health 650 California Street, Suite 700San Francisco, CA 94108415-496-9302https://www.ooda-health.com/ Key contact Name Title Giovanni Colella CEO SAN FRANCISCO, CA, Company focused on removing waste and inefficiency from healthcare administration, has completed a $40.5M round of Series A funding. OODA Health, a new company focused on removing waste and inefficiency from healthcare administration, today announced […]
18
Set
Set
Saykara Seattle, WAhttps://www.saykara.com/ Key contact Name Title Harjinder Sandhu CEO SEATTLE, WA, Saykara, the leading voice and AI-powered virtual assistant for physicians, announced today an investment of $5 million. The round was led by SpringRock Ventures, a venture fund focused on the convergence of health care and technology. Other investors include NewYork-Presbyterian Hospital, Elevate Innovation […]
MIACH Orthopaedics 300 Longwood Ave.Boston, MA 02115 Key contact Name Title Martha Murray Founder BOSTON, MA, Company dedicated to developing bio-engineered surgical implants for connective tissue repair, announced today it completed $22.5M in financing. MIACH Orthopaedics, Inc., a privately held company dedicated to developing bio-engineered surgical implants for connective tissue repair, announced today it completed […]
14
Set
Set
HYP3R San Francisco, CAhttps://hyp3r.com/ Key contact Name Title Carlos Garcia CEO SAN FRANCISCO, CA, Leading innovator in location-based marketing, announced its Series A financing of $17 million. HYP3R, the leading innovator in location-based marketing, announced its Series A financing of $17 million with participation from Structure Capital, Rokk3r Fuel, Thayer Ventures, Silicon Valley Bank and […]
CODA Biotherapeutics 329 Oyster Point Boulevard, 3rd FloorSouth San Francisco, CA 94408https://www.codabiotherapeutics.com/ Key contact Name Title Michael Narachi, MBA President & CEO SOUTH SAN FRANCISCO, CA, CODA Biotherapeutics today debuted with a $19 million Series A financing. CODA Biotherapeutics, a preclinical-stage biopharmaceutical company developing a chemogenetic gene therapy platform for the treatment of intractable diseases, […]
13
Set
Set
Growers Holdings Raleigh, NC984-500-3797https://www.growers.ag/ Key contact Name Title Steven Valencsin CEO & Founder RALEIGH, N.C., Growers Holdings has raised a $5M Series A financing led by St. Louis-based Lewis and Clark Ventures. Growers provides software + services that help farmers and their trusted advisors utilize farm data to simplify decision making and increase profitability. In […]
Solid Power 486 S. Pierce Ave., Unit ELouisville, CO 80027303-717-5174http://solidpowerbattery.com/ Key contact Name Title Doug Campbell CEO LOUISVILLE, CO, Industry leader in safe, high-energy, and cost competitive all solid-state batteries (ASSB), has closed $20M in a Series A investment round. Louisville, Colo.-based Solid Power, an industry leader in safe, high-energy, and cost competitive all solid-state […]
12
Set
Set
System1 Biosciences 1405 Minnesota StreetSan Francisco, CA 94107929-575-5579https://system1.bio/ Key contact Name Title Sean Escola CEO SAN FRANCISCO, CA, Neurotherapeutics company announced the completion of $25 million in Series A financing. System1 Biosciences, Inc, a San Francisco-based neurotherapeutics company that employs phenotypic screening to discover novel drugs for neurological and psychiatric disorders, today announced the completion […]